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Public Veterinary Medicine:
Public Health
National surveillance for human and pet contact
with oral rabies vaccine baits, 2001–2009
Amira A. Roess, phd; Nancy Rea, phd; Edith Lederman, md; Virginia Dato, md; Richard Chipman, ms;
Dennis Slate, phd; Mary G. Reynolds, phd; Inger K. Damon, md, phd; Charles E. Rupprecht, vmd, phd
Objective—To determine the rate and absolute number of human and pet exposures to
oral rabies vaccine (ORV) bait containing liquid vaccinia rabies glycoprotein recombinant
vaccine and to evaluate factors that might affect human contact with bait to modify the
program and reduce human exposure to the vaccine.
Design—Retrospective analysis of surveillance data (2001 to 2009).
Sample—Reports on human and pet contact with ORV baits in states with ORV surveillance programs.
Procedures—Data were collected from passive, multistate ORV surveillance systems in
Alabama, Arizona, Florida, Georgia, Maine, Maryland, Massachusetts, New Hampshire,
New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Vermont, Virginia, and West Virginia. Data collected included the nature of human or pet contact with
bait and vaccine, the caller’s knowledge of the ORV bait program, local human population
density, and other relevant demographic data.
Results—All 18 states participated in the surveillance program for at least 1 year, for a combined 68 years of observation. One thousand four hundred thirty-six calls were reported,
representing 3,076 found baits (6.89/100,000 baits dropped); 296 (20%) calls were related
to human contact with ruptured bait, and 550 (38%) involved pet contact with the bait. Six
adverse events in humans were reported, one of which required hospitalization. Fifty-nine
adverse events in pets were noted, all of which were nonserious.
Conclusions and Clinical Relevance—Findings from surveillance activities have been
used to improve baiting strategies and minimize human and pet contact with ORV baits.
Overall, human and pet contact with ORV baits was infrequent. Surveillance has led to
early identification of persons exposed to ORV and rapid intervention. (J Am Vet Med Assoc
2012;240:163–168)

R

abies, a zoonotic disease caused by infection with
RNA viruses in the family Rhabdoviridae, genus
Lyssavirus, is almost always fatal in humans.1 Canine
vaccination and stray animal control programs implemented in 1946 have significantly reduced domestic
animal and human rabies cases in the United States
from 8,384 domestic dog cases2,3 and 33 human cases in
19462,3 to 75 dog cases2,3 and 2 human cases in 2008.4–6

Abbreviation
ORV

Oral rabies vaccine

During this same period, there was a marked increase
in wildlife rabies. Raccoon rabies, first identified as a
concern in the 1940s,3 became endemic in the Eastern
states and Southern Canada.7–9 Most reported cases of
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wildlife rabies occur among raccoons (Procyon lotor),
skunks (primarily Mephitis mephitis), gray foxes (Urocyon cinereoargenteus), and multiple species of bats,
and these species are now the primary sources of rabies
in dogs.8,10,11 Each year, an estimated 16,000 to 39,000
persons in the United States come in contact with rabid
and potentially rabid animals and receive rabies postexposure prophylaxis.5,12
Rabies control measures include vaccination of domestic animals and surveillance programs to monitor
rabies trends in humans and animals. Oral rabies vaccine programs were first initiated to complement traditional rabies control measures in Europe in 1977. The
current USDA-licensed ORV consists of a rabies virus
glycoprotein gene inserted into the thymidine kinase
locus of the Copenhagen strain of vaccinia virus13,14,a;
the deletion of a functional thymidine kinase results
in attenuation of the virus.15 The oral vaccinia rabies
glycoprotein recombinant vaccinea is packaged and distributed in heat-sealed plastic packets or sachets that
are coated with fishmeal or placed within a fishmeal
block to entice uptake by raccoons (P lotor), gray foxes
(U cinereoargenteus), and coyotes (Canis latrans). Following oral exposure to the vaccine, the animals develop neutralizing antibodies to rabies virus. The use of
ORV began in Canada in 1985 and in the United States
in 1990. In 1995, the USDA’s National Rabies Management Program established the ORV program to prevent
the further spread of wildlife rabies and eventually
eliminate carnivore rabies in the United States through
methods that involve the use of oral rabies vaccination
targeting wildlife.16 It is anticipated that as the number
of vaccinated animals in the population increases, development of herd immunity will minimize the spread
of disease to other wildlife, domestic animals, and
humans. Oral rabies vaccine programs to combat the
spread of raccoon rabies are currently ongoing in 16
eastern states; in Texas and Arizona, baits are distributed for rabies control in gray foxes and coyotes.
Vaccinia virus, the viral component of the oral vaccinia rabies glycoprotein recombinant vaccine,a is an
orthopoxvirus used as the viral vector of the vaccine.
The vaccinia virus strain used in the ORVa has been
attenuated. Nevertheless, human (percutaneous) exposure to ruptured sachets can result in vaccinia virus
infection.17,18 Severe outcomes are possible among persons who are immunocompromised and for those with
atopic dermatitis, exfoliative dermatologic conditions,
and other conditions considered to be contraindications to smallpox vaccination.14,17,18
Since 1990, > 200 million doses of the ORVa have
been distributed in the United States. However, reports
of human and domestic animal contact with ORV baits
have been relatively rare.8,19 In Pennsylvania, human exposure to the liquid vaccine was reported to occur via
dogs that find a bait and puncture the sachet when humans attempt to remove the bait from the dog’s mouth.19
Oral rabies vaccine bait distribution areas and
methods (aerial or ground hand baiting) are selected to
optimize opportunities to vaccinate wildlife but minimize the chance of contact with non–target species,
such as humans and pets. Fixed-wing aircraft are the
most effective means for distributing large numbers of
164
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ORV baits. Hand baiting is important in urban and suburban areas, where raccoon (P lotor) densities may be
elevated and there may be limited habitat available for
baiting as well as safety risks associated with distributing baits by air. Prior to baiting, communication campaigns such as press releases, public service announcements, and ORV media days at local airports where
ORV operations are being coordinated are conducted
to raise awareness. In addition, printed on each bait is a
toll-free telephone number for the federal, state, or local agency supporting the local ORV program. If a person finds bait, he or she can call that number to obtain
information about the ORV or to report (human or pet)
contact with bait. This information forms the basis of a
bait contact passive surveillance system.
State-based bait programs consist of 1 to 2 baiting distributions/y, and surveillance for human and
pet contact with bait is conducted annually. Surveillance data have been used by agencies involved in ORV
programs to improve local communications programs,
modify baiting strategies, and reduce human and pet
contact with baits by reducing aerial baiting in areas
of high human population density and through better
habitat targeting through hand baiting. The purpose of
the study reported here was to determine the number of
human and pet contact events with baits containing the
ORV from 2001 to 2009. In this report, we also describe
a severe adverse event in an immunocompromised individual reported to the surveillance system to illustrate
how the surveillance system led to the prompt identification of the patient.
Materials and Methods
Surveillance system—Since 2001, the USDA Wildlife Services Program has maintained a surveillance system of human and pet contact with ORV baits. Reports
of human or pet contact with baits occur principally via
1 of 2 mechanisms: from a citizen who has found the
bait and calls the toll-free number printed on the baits
or from federal or local agencies that were contacted
after a bait was found. Additional information about
the nature and circumstances of the contact is then
collected by personnel in the appropriate local agency
(typically a State or County Health Department). The
nature of the information collected by individual jurisdictions varies but usually includes the circumstances
surrounding bait discovery, where it was found, how it
was retrieved, and whether the sachet containing the
vaccine was punctured. At the end of each ORV baiting
season, federal and local offices in participating states
complete a standardized surveillance questionnaire,
which is designed to capture reports of human and pet
contact with the bait. Eighteen states have participated
in this surveillance system: Alabama, Arizona, Florida,
Georgia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, North Carolina, Ohio,
Pennsylvania, Tennessee, Texas, Vermont, Virginia, and
West Virginia.
Statistical analysis—Surveillance forms were created by use of commercial software,b and data were analyzed with statistical software.c Surveillance data were analyzed to determine the rates of human and pet exposure
JAVMA, Vol 240, No. 2, January 15, 2012

to ORV baits from 2001 to 2009. Rates of calls, exposures,
and outcomes per 100,000 baits distributed are presented. Frequencies for particular locations where baits were
found, descriptions of the nature of human and pet contact, and a summary of adverse events involving humans
and pets were evaluated. Rate ratios were calculated to
determine differences in the distribution of responses between geographic variables potentially affecting human
contact with bait (bait density, human population density,
and bait distribution method) and P values are reported.
Low population density was categorized as < 150 people/
km2, high population density as ≥ 150 people/km2, low
bait density as ≤ 75 bait-vaccine units/km2, and high bait
density as > 75 bait-vaccine units/km2.

During the study period, there were 1,436 calls
to the helpline and 3,076 baits were reported to have
been found (6.89/100,000 baits distributed). The rate
of baits found peaked in 2004 and then decreased to
below 2001 values. Two hundred ninety-six (20%)
calls were related to human contact with ruptured
baits, and 550 (38%) involved pet contact with the
bait, which were not mutually exclusive. The rates
for pets finding bait, pets ingesting bait, and adverse
events were 1.23, 0.70, and 0.08/100,000 baits distributed, respectively. Callers reported that pets had clinical signs including lethargy, diarrhea, and vomiting.
The rates of possible human exposure (defined as skin
Table 2—Number and rates (per 100,000 ORV baits distributed)
of calls received during a 9-year (2001 through 2009) multistate
surveillance period and rates of human and pet contact.

Results
From 2001 through 2009, > 80 million ORV baits
were distributed in 18 states (Table 1). Number of years
participating in the surveillance system during this period differed among states; West Virginia, Ohio, Vermont, New Hampshire, Texas, and New York each had
program activities for the length of the surveillance period (n = 9). Time with ORV bait program activities was
8 years in Maryland, Pennsylvania, Virginia, Tennessee,
and New Jersey; 7 years in Maine; 6 years in Florida,
Georgia, and Alabama; and 5 years in North Carolina,
Massachusetts, and Arizona. The cumulative number of
baits distributed between 2001 and 2009 ranged from
133,449 in Arizona to 24,172,750 in Texas. The surveillance program captured information for a combined
68 years of observation (50.7%); 44,635,548 baits were
distributed during this observation period, and 3.51
calls/100,000 baits distributed were reported (Table 2).
The rate of calls to the helpline and the rate of bait incidences varied over the surveillance period. The rate
(per 100,000 baits distributed) of calls regarding pet
contact with bait (2.53) was higher than the rate of calls
regarding human contact with bait (0.47).

State

Rate of
calls (No.)

Alabama
Arizona
Florida
Georgia
Maine
Maryland
Massachusetts
New Hampshire
New Jersey
New York
North Carolina
Ohio
Pennsylvania
Tennessee
Texas
Vermont
Virginia
West Virginia
Total

3.46 (37)
0.77 (1)
1.12 (68)
1.46 (5)
16.19 (5)
8.4 (13)
38.77 (57)
9.31 (27)
0 (0)
3.42 (103)
0.95 (4)
4.81 (412)
6.76 (431)
6.14 (79)
0.13 (8)
2.65 (36)
0.30 (7)
1.29 (143)
3.51 (1,436)

Rate of human
contact (No.)*
0.09 (1)
0.00 (0)
0.49 (4)
0.00 (0)
0.00 (0)
0.00 (0)
6.59 (6)
0.00 (0)
0.00 (0)
NA
0.00 (0)
2.02 (45)
0.84 (16)
0.08 (1)
0.00 (0)
0.72 (7)
0.33 (2)
0.28 (7)
0.47 (89)

Rate of pet
contact (No.)*
1.60 (18)
0.00 (0)
4.95 (40)
0.58 (2)
1.66 (2)
5.82 (9)
54.94 (50)
0.00 (0)
0.00 (0)
NA
0.24 (1)
7.59 (169)
4.10 (78)
3.58 (46)
0.08 (5)
2.48 (24)
0.33 (2)
1.28 (32)
2.53 (478)

*Because of missing data, only information on rates of human
and pet contact reported to the surveillance programs in 2008 and
2009 was included.
NA = Not available.

Table 1—Multistate vaccination programs that used oral vaccinia rabies glycoprotein recombinant vaccinea in the United States from
2001 to 2009.

State (year program began)

No. of y of ORV program			
activities (No. of y			
captured in surveillance)
Area (km2)

Alabama (2004)
Arizona (2005)
Florida (1995)
Georgia (2004)
Maine (2003)
Maryland (2002)
Massachusetts (2008)
New Hampshire (1997)
New Jersey (1992)
New York (1995)
North Carolina (2005)
Ohio (1998)
Pennsylvania (2002)
Tennessee (2002)
Texas (1995)
Vermont (1997)
Virginia (2002)
West Virginia (2001)
Total

6 (2)
5 (2)
6 (6)
6 (2)
7 (4)
8 (2)
5 (2)
9 (4)
8 (1)
9 (2)
5 (2)
9 (9)
8 (7)
8 (2)
9 (2)
9 (4)
8 (7)
9 (8)
134 (68)

8,569
1,400
8,185
1,451
690
1,086
988
299
480
20,003
2,917
13,913
12,637
11,570
107,599
7,255
5,053
20,085
224,182

Population
density (No. of
people/km2)*
190.67
141.98
828.83
210.07
366.63
1336.81
223.64
106.93
199.54
365.61
145.71
232.84
266.63
119.03
21.19
54.16
60.67
59.47
138

Total No. of ORV baits
distributed (No. distributed
during surveillance)
4,279,161 (1,070,029)
135,449 (129,600)
3,767,453 (3,025,449)
686,868 (342,487)
632,123 (216,123)
2,172,105 (154,710)
514,823 (147,036)
1,348,886 (429,605)
359,200 (40,000)
11,135,545 (3,015,732)
924,273 (419,455)
8,559,676 (8,559,676)
7,595,083 (6,374,743)
3,938,225 (1,286,637)
24,172,750 (6,026,998)
2,245,992 (1,358,616)
2,619,735 (2,299,344)
11,127,540 (11,127,540)
86,214,887 (44,635,548)

*Population density of areas baited from 2008 census data.
JAVMA, Vol 240, No. 2, January 15, 2012
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contact with bait), probable skin exposure defined as
skin or mucosa contact with broken bait, and adverse
events were 0.66, 0.04, and 0.007/100,000 baits distributed, respectively (n = 6).
Adverse events in humans reported by callers included rash, itchy skin, redness, and swelling. All of these
involved someone having handled bait that had been ruptured by a pet dog. Five of the adverse events in humans
involved skin rashes or dermatologic reactions, presumably to the fishmeal bait, and 1 resulted in a serious
vaccinia virus infection.20 Briefly, the Pennsylvania
Department of Health received a report that a 35-yearold woman, who was taking immunosuppressive medications to control symptoms of inflammatory bowel
disease, picked up a bait ruptured by her dog. At the
time, the woman had been picking blackberries and
there were freshly abraded patches of skin on her right
hand and wrist. Liquid vaccine leaked onto the abraded
skin. When she returned home, after approximately 30
minutes, she was able to call the ORV helpline number.
The ORV helpline contacted a Public Health Physician
at her state health department who was concerned be-

cause of the specific immunosuppressive agents taken
and the type and degree of exposure. The women received immediate instructions on what to look for and
who to call if any lesions developed. Within 24 hours
after the call, the women’s personal physicians and experts at the CDC were notified. Pictures of the injuries
were obtained, and serologic analysis to obtain baseline
data was performed. On day 4 following the exposure,
she called again because several red papules appeared
and she was subsequently diagnosed with vaccinia infection20 (Figure 1).
Of 1,272 callers, 347 (27%) were aware of the
ORV baiting program, and 928 of 1,404 (66.1%) had
called the ORV helpline number. Forty-eight percent of
baits were found on residential property, 42.7% were
retrieved by pets, 5.8% were found on streets, and the
rest were found in wooded areas. Human (R2 = 7.8;
P = 0.024) and pet (R2 = 10.96; P = 0.043) contact
with bait was considerably higher in areas of high human population densities (≥ 150 people/km2), compared with contact in areas of low population densities
(< 150 people/km2; Table 3). Ground baiting is the
preferred method of bait distribution
in areas with high human population
densities, and baits are distributed at a
low density (≤ 75 bait-vaccine units/
km2). Therefore, human and pet contact
with bait increased as the percentage of
ground baiting increased. Contact rates
for both humans and domestic animals
did not increase with higher bait density,
presumably because baits are distributed
at higher density in areas with lower human population density.
Discussion

Figure 1—Photograph of female human patient (age, 35 years) receiving immunosuppressive
medications for inflammatory bowel disease, with vaccinia virus lesions and pronounced redness and edema of her right hand on day 10 after contact with an animal ORV bait.

Since 2000, > 100 million doses
of the ORV have been distributed in
the United States. The present study
found that during the period from 2001
through 2009, the rate of calls to the
helpline remained relatively constant; a
small increase was observed from 2007
through 2009, which may have been related to sizable increases in surveillance
participation. Nominally higher rates of
found baits were observed during the pe-

Table 3—Human and pet contact rates per 100,000 ORV baits distributed in 2008 in all states excluding
Arizona, by human population and bait density.

Variable

Rate ratio (95% CLs) 			
of human contact			
with bait
P value

Rate ratio (95% CLs)		
of pet contact
with bait
P value

Population density (high vs low)
7.80 (1.31–46.5)
0.024
10.96 (1.08–111.35)
Bait density (high vs low)
0.37 (0.116–1.21)
0.101
0.25 (0.05–1.23)
Ground baiting				
$ 85%
9.00 (3.44–23.53)
, 0.001
11.28 (3.57–35.64)
10%–85%
Referent		
Referent
, 10%
0.13 (0.01–1.91)
0.137
0.05 (0.00–8.43)

0.043
0.089
, 0.001
0.249

Low population density was categorized as , 150 people/km2, high population density as $ 150 people/
km2, low bait density as # 75 bait-vaccine units/km2, and high bait density as . 75 bait-vaccine units/km2.
CL = Confidence limit.
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riod from 2001 to 2004; however, this may have been
related to an increase in the number of bait distribution
programs, given that 13 states initiated ORV bait programs during this period. Historically, the highest rates
of found baits have been observed during the inaugural
bait program in individual states. Enhanced surveillance during this period is essential for modifications
to future bait distribution plans.
Surveillance data suggest that human and domestic
animal contact with ORV baits has been and continues to be rare. In the present study, the rate of reported
contact with baits (1.29/100,000 baits distributed) was
similar to those that have been found in other studies,
which have ranged from 0.12 to 50 reports/100,000
baits distributed.8,14,19,21 Pets continue to be the major
source of human exposure to the liquid vaccine component of ORV baits.14,19 Most baits were found by pet
dogs, and all of the adverse events in humans were
linked to retrieving bait from a pet dog. A published
analysis19 of local surveillance data from Pennsylvania
in 2003 demonstrated similar rates (66/70 pets that
found baits were dogs).19 Furthermore, 7 of 8 human
exposures to vaccine occurred after a dog had ruptured
the sachet containing the vaccine in baits.19 Another
analysis in Ohio indicated that 18 of 20 reports of probable exposures to vaccine involved dogs; 3 of 20 reports
involved persons with health conditions that are contraindications for vaccinia virus vaccination.14
The vaccinia rabies glycoprotein virus is a selfreplicating attenuated agent that may cause adverse
events. Early identification of persons at high risk for
developing serious vaccinia virus infection is important
to avoid adverse outcomes. Surveillance and early detection led to prompt identification of an immunocompromised individual who was exposed to vaccine liquid
and allowed for a timely intervention. Medical personnel were alerted of possible vaccinia infection prior to
symptom onset, and rapid implementation of treatment
was possible.
In a previous study,8 increased human population
density was also significantly related to increased rates
of human and pet contact with the baits. The ORV program uses ground (hand) baiting in areas with higher
human population density to reduce the risk of human
exposure. Given that there is a consequential relationship between increased human and pet contact in areas with the highest ground baiting, low numbers of
bait contacts may not be completely avoidable (Table
3). Just as surveillance during inaugural programs was
important to inform bait distribution plans to lower
numbers of found baits, it remains essential in identifying areas that may have demographic or other changes
from season to season that lead to an increase in found
baits. Continual surveillance is important for further
refinement of bait distribution and identification of
higher-than-expected rates of found baits.
Community outreach is an integral component of
ORV programs. The extent to which outreach proved
useful to those individuals who ultimately found baits
(callers) could not be determined from the surveillance
data summarized in this study because these data are
not routinely collected at the state level. However, we
did find that a large number of callers (n = 598) reJAVMA, Vol 240, No. 2, January 15, 2012

ported that they did not know about ORV activities.
Increased media outreach, public service announcements, and newspaper advertisements may improve
knowledge of the baiting campaigns,8,19 as in Pennsylvania, where a sharp decrease in reports of bait contact
from 2003 to 2004 (from 6.1 to 2.9/100,000 baits distributed) was attributed to modifications made to the
program, including an increase in media outreach in
smaller markets and increased hand baiting.19 The establishment of communication campaigns that support
surveillance objectives through evolving social media
such as microblogging and social networking services
is currently under consideration.
The adverse event described in the present report is
the second documented case of vaccinia virus infection
associated with the ORV. The first instance involved a
pregnant 28-year-old Ohio resident with epidermolytic
hyperkeratosis who was bitten while pulling a ruptured
bait from her dog’s mouth.14 During the course of a 34day infection, she developed swelling, erythema, left axillary adenopathy, pustules, and necrotic scabs; her skin
ultimately healed, and the pregnancy followed a normal
progression.14 Both documented instances of human
vaccinia virus infections caused by the ORV occurred
after baits were found and the sachets were punctured
by dogs,14,20 and all adverse events in humans involved
interaction with pet dogs that found baits.8,14,19–21 These
observations suggest that owners should not attempt to
remove baits from their dog’s mouth and instead should
use gloves or plastic bags to pick up and examine baits.
Results of data analysis in this report have several
potential limitations. First, this is a passive surveillance
system that relies on voluntary reporting, and it is likely to underestimate the number of contacts with bait.
Information collected from individuals calling differs
among states; each state has its own surveillance form,
and type of information and level of detail differ among
states. Enhanced standardization of protocols is recommended. Between 2005 and 2007, half of the ORV baiting programs did not complete reporting to the surveillance system. Increased follow-up to all states resulted
in a sizable increase of participation, up to 95% in 2008
and 2009.
The surveillance system in place has been useful in
collecting timely pet and human ORV exposure data.
Refinements and standardization of the surveillance
system are needed, particularly at the individual program level. Communication campaigns are an essential
method to educate the public about ORV and the associated risk of contact with baits and vaccine, and these
should be modified during baiting activities to enhance
outreach.
a.
b.
c.

Raboral V-RG, Merial Inc, Duluth, Ga.
Adobe LiveCycle, Adobe Systems Inc, San Jose, Calif.
SPSS, version 17.0, SPSS Inc, Chicago, Ill.
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